Trials / Completed
CompletedNCT04476238
Inosine Energy Expenditure Study
Randomized Cross-over Trial to Investigate the Effect of Inosine on Human Energy Expenditure
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- University Hospital, Basel, Switzerland · Academic / Other
- Sex
- Male
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
Investigators want to test whether the intake of the nucleoside inosine increases the human energy expenditure. Inosine occurs as a metabolic intermediate in the human body and is sometimes taken as a dietary supplement by athletes. For this purpose, investigators will measure the basal metabolic rate by indirect calorimetry. Study participants will then take inosine dissolved in water or placebo and energy expenditure will be assessed again.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Inosine | 2 grams of inosine dissolved in 250 ml water taken by mouth |
| OTHER | Placebo | 250 ml water taken by mouth |
Timeline
- Start date
- 2022-02-28
- Primary completion
- 2022-12-31
- Completion
- 2023-04-30
- First posted
- 2020-07-20
- Last updated
- 2023-09-28
Locations
1 site across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT04476238. Inclusion in this directory is not an endorsement.